Clinical Trial Update: Add-on Aliskiren Treatment in Patients With Chronic Congestive Heart Failure [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating add-on aliskiren for patients with chronic heart failure; the current trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Tekturna (aliskiren)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Congestive Heart Failure | Phase 4 | Status: UNKNOWN